The Readout Loud
Episode 42: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Are megamergers bad for business? Is it time for biotech's biggest gathering to find a new home? And can a "need" be anything but "unmet"?